Literature DB >> 2208703

Setting analytical goals for random analytical error in specific clinical monitoring situations.

C G Fraser1, P Hyltoft Peterson, M L Larsen.   

Abstract

Strategies abound for the setting of analytical goals in clinical chemistry. Many, especially those more recently proposed for particular clinical situations, are concerned with tests used in diagnosis. We suggest a general theory for the setting of goals in situations that specifically involve the monitoring of individuals. Goals are calculated from the formula CVA less than [(delta c 2/2Z2)-CVB2]1/2, where CVA is the analytical imprecision (as coefficient of variation, CV); delta c is the percentage change in serial results that is considered clinically significant; Z is the Z-statistic, which depends only on the probability selected for statistical significance; and CVB is the average inherent within-subject biological variation (as CV). Examples given show applications in hematology and in monitoring diabetes mellitus, chronic renal failure, and hepatitis. The derived goals are for total random analytical error (imprecision and intermittent systematic variation), and provide objective criteria that should be achieved in practice. The effect of analytical variability on both variability in test results and the probability that a stated change can be considered significant should be calculated whether or not the goals are attained.

Entities:  

Mesh:

Year:  1990        PMID: 2208703

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  12 in total

1.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

2.  Assessment of extracellular dehydration using saliva osmolality.

Authors:  Brett R Ely; Samuel N Cheuvront; Robert W Kenefick; Marissa G Spitz; Kristen R Heavens; Neil P Walsh; Michael N Sawka
Journal:  Eur J Appl Physiol       Date:  2013-10-23       Impact factor: 3.078

3.  Quality leadership and quality control.

Authors:  Tony Badrick
Journal:  Clin Biochem Rev       Date:  2003-08

Review 4.  Statistical methods for assessing measurement error (reliability) in variables relevant to sports medicine.

Authors:  G Atkinson; A M Nevill
Journal:  Sports Med       Date:  1998-10       Impact factor: 11.136

Review 5.  Evaluation of heart failure biomarker tests: a survey of statistical considerations.

Authors:  Arkendra De; Kristen Meier; Rong Tang; Meijuan Li; Thomas Gwise; Shanti Gomatam; Gene Pennello
Journal:  J Cardiovasc Transl Res       Date:  2013-05-14       Impact factor: 4.132

6.  Biological variation of arginine vasopressin.

Authors:  Kurt J Sollanek; Jeffery S Staab; Robert W Kenefick; Samuel N Cheuvront
Journal:  Eur J Appl Physiol       Date:  2020-01-22       Impact factor: 3.078

7.  Reference intervals of trimester-specific thyroid stimulating hormone and free thyroxine in Chinese women established by experimental and statistical methods.

Authors:  Lican Han; Wei Zheng; Yanhong Zhai; Xin Xie; Jingnan Zhang; Shaozu Zhang; Zhen Zhao; Zheng Cao
Journal:  J Clin Lab Anal       Date:  2017-11-04       Impact factor: 2.352

8.  Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy.

Authors:  M K Tuxen; G Sölétormos; P Dombernowsky
Journal:  Br J Cancer       Date:  2001-05-18       Impact factor: 7.640

9.  Detection and monitoring of hypermethylated RASSF1A in serum from patients with metastatic breast cancer.

Authors:  Søren Kristiansen; Dorte Nielsen; György Sölétormos
Journal:  Clin Epigenetics       Date:  2016-04-01       Impact factor: 6.551

Review 10.  Homeostatic Control of the Thyroid-Pituitary Axis: Perspectives for Diagnosis and Treatment.

Authors:  Rudolf Hoermann; John E M Midgley; Rolf Larisch; Johannes W Dietrich
Journal:  Front Endocrinol (Lausanne)       Date:  2015-11-20       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.